Summit Therapeutics (SMMT) Q1 2026 Earnings

12MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Next
-0.76
-0.54
-0.31
-0.09

Details

Expected EPS
-0.087048
Actual EPS
N/A
Surprise EPS
0.09
Surprise Percent
+100%

Description

Summit Therapeutics (SMMT) will report earnings of for Q1 2026 on March 12, 2026.

0 Comments

Share your thoughts